LOGIN
Diclofenac-Hyaluronate Conjugate Injection for Knee Osteoarthritis
October 2021
Diclofenac-Hyaluronate Conjugate Injection for Knee Osteoarthritis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Efficacy and Safety of Diclofenac-Hyaluronate Conjugate (Diclofenac Etalhyaluronate) for Knee Osteoarthritis: A Randomized Phase III Trial in Japan.
Arthritis Rheumatol. 2021 Sep;73(9): 1646-1655.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Four hundred and forty patients with knee osteoarthritis were randomized to receive a series of intra-articular diclofenac-hyaluronate conjugate (Diclofenac Etalhyaluronate) injections (DF-HA) (n=220) or placebo injections (n=220). The primary outcome of interest was the change in baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale. Secondary outcom...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.